Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium

Molecular Human Reproduction

Volumn 13, Issue 9, 2007, Pages 641-654

  Catalano, R D ^a   Critchley, H O ^b   Heikinheimo, O ^c   Baird, D T ^b   Hapangama, D ^b   Sherwin, J R A ^a   Charnock Jones, D S ^a   Smith, S K ^a   Sharkey, A M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Capacitation; ERp57; Gamete fusion; Spermatozoa; Testes

Indexed keywords

CHEMOKINE; COMPLEMENTARY DNA; MATRIX METALLOPROTEINASE; MIFEPRISTONE; PROGESTERONE; PROSTAGLANDIN; THYROGLOBULIN; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROID PEROXIDASE; THYROXINE; THYROXINE DEIODINASE; WNT PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MENSTRUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; THYROID HORMONE METABOLISM; THYROID HORMONE SYNTHESIS; TRANSCRIPTION REGULATION;

ADULT; CHEMOKINES; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HORMONE ANTAGONISTS; HUMANS; IODIDE PEROXIDASE; MATRIX METALLOPROTEINASES; MENSTRUATION; MIDDLE AGED; MIFEPRISTONE; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGESTERONE; PROSTAGLANDINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYROGLOBULIN; WNT PROTEINS;

EID: 34548435116     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam021     Document Type: Article

References (65)

1. Aghajanova L, Stavreus-Evers A, Landgren B et al. Thyroid hormone receptors in human endometrium. Hum Reprod 2005; 20(Suppl 1):180.
2. Allan G, Campen C, Hodgen G et al. Identification of genes with differential regulation in primate endometrium during the proliferative and secretory phases of the cycle. Endocrine Res 2003;29 53-65.
3. Baird DT, Cameron ST, Critchley HO et al. Prostaglandins and menstruation. Eur J Obstet Gynecol Reprod Biol 1996;70:15-17.
4. Battersby S, Critchley HO, de Brum-Fernandes AJ et al. Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle. Reproduction 2004;127 79-86.
5. Borthwick JM, Charnock-Jones DS, Tom BD et al. Determination of the transcript profile of human endometrium. Mol Hum Reprod 2003;9: 19-33.
6. Bruner KL, Rodgers WH, Gold LI et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 1995;92:7362-7366.
7. Bugalho MJ, Domingues, RS, Pinto AC et al. Detection of thyroglobulin mRNA transcripts in peripheral blood of individuals with and without thyroid glands: Evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 2001;145:409-413.
8. Bussen S, Steck T, Dietl J. Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in-vitro fertilization failure. Hum Reprod 2000;15:545-548.
9. Cameron IT, Leask R, Kelly RW et al. Endometrial prostaglandins in women with abnormal menstrual bleeding. Prostaglandins Leukot Med 1987;29:249-257.
10. Carmeliet P, Moons L, Lijnen R et al. Urokinase generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Gen 1997;17:439-444.
11. Casslen B, Andersson A, Nilsson IM et al. Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture. Proc Soc Exp Biol Med 1986;182:419-424.
12. Casslen B, Urano S, Ny T. Progesterone regulation of plasminogen activator 1 (PAI-1) antigen and mRNA level in human endometrial stromal cells. Thromb Res 1992;66:75-87.
13. Catalano RD, Yanaihara A, Evans AL et al. The effect of RU486 on the gene expression profile in an endometrial explant model. Mol Hum Reprod 2003;9:465-473.
14. Cheon YP, Li Q, Xu X et al. A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation. Mol Endocrinol 2002;16:2853-2871.
15. Chwalisz K, Brenner RM, Fuhrmann UU et al. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium. Steroids 2000;65:741-751.
16. Critchley HO, Jones RL, Lea RG et al. Role of inflammatory mediators in human endometrium during progesterone, withdrawal and early pregnancy. J Clin Endocrinol Metab 1999;84:240-248.
17. Critchley HO, Kelly RW, Brenner RM et al. The endocrinology of menstruation - a role for the immune system. Clin Edocrinol 2001;55: 701-710.
18. Critchley HOD, Kelly RW, Brenner RM et al. Antiprogestins as a model for progesterone withdrawal. Steroids 2003;68 1061-1068.
19. Critchley HO, Robertson KA, Forster T et al. Gene expression profiling of mid to late secretory phase endometrial biopsies from women with menstrual complaint. Am J Obstet Gynecol 2006;195 406.pel-406.e6.
20. Danielsson KG, Marions L, Bygdeman M. Effects of mifepristone on endometrial receptivity. Steroids 2003;68:1069-1075.
21. Freitas S, Meduri G, Le Nestour E et al. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod 1499;61:1070-1082.
22. Gardner RM, Kirkland JL, Ireland JS et al. Regulation of the uterine response to estrogen by thyroid hormone. Endocrinology 1978;103:1164-1172.
23. Garzo V, Liu J, Ulmann A et al. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. J Clin Endocrinol Metab 1988;66:508-517.
24. Ghosh D, Kumar PG, Sengupta J. Effect of early luteal phase administration of mifepristone (RU486) on leukaemia inhibitory factor, transforming growth factor beta and vascular endothelial growth factor in the implantation stage endometrium of rhesus monkey. J Endocrinol 1998;157:115-125.
25. Hampton AL, Salamonsen LA. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 1994;141:R1-R3.
26. Hannan NJ, Jones RL, Critchley HO et al. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodelling. J Clin. Endocrinol Metab 2004;89:6119-6129.
27. Hapangama DK, Critchley HO, Henderson TA et al. Mifepristone induced vaginal bleeding is associated with increased immunostaining for cycloxygenase-2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium. J Clin Endocrinol Metab 2002;87:5229-5234.
28. Haraguchi K, Shimura H, Lin L et al. Differentiation of rat preadipocytes is accompanied by expression of thyrotropin receptors. Endocrinology 1996; 137:3200-3205.
29. Henderson TA, Saunders PT, Moffett-King A et al. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 2003;88:440-449.
30. Hiraoka N, Allen E, Apel IJ et al. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998;95:365-377.
31. Horcajadas JA, Sharkey AM, Catalano RD et al. Effect of an intrauterine device on the gene expression profile of the endometrium. J Clin Endocrinol Metab 2006;91:3199-3207.
32. Inuwa I, Williams MA. Morphometric study on the uterine horn and thyroid gland in hypothyroid and thyroxin treated hypothyroid rats. J Anat 1996;188:383-393.
33. Jabbour HN, Kelly RW, Fraser HM et al. Endocrine regulation of menstruation. Endocrin Rev 2006;27:17-46.
34. Johannisson E, Oberholzer M, Swahn ML et al. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception 1989;39:103-117.
35. Jones RL, Salamonsen LA, Findlay JK. Activin-A promotes human endometrial stromal cell decidualization in vitro. J Clin Endocrinol Metab 2002;87:4001-4004.
36. Jones RL, Hannan NJ, Kaitu'u TJ et al. Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab 2004;89: 6155-6167.
37. Jones RL, Findlay JK, Farnworth PG et al. Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 2006;147:724-732.
38. Kao, LC, Tulac S, Lobo S et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002;143:2119-2138
39. Kennedy TG, Doktorcik PE. Uterine decidualization in hypophysectomized-ovariectomized rats: Effects of pituitary hormones. Biol Reprod 1988;39: 318-328.
40. Krikun G, Schatz F, Taylor R et al. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab 2005;90:1812-1818.
41. Lessey BA, Killam AP, Metzger DA et al. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988;67:334-340.
42. Li Q, Cheon YP, Kinnan A et al. A novel pathway involving progesterone receptor, 12/15 lipoxygenase-derived eicosanoids and peroxisome proliferator-activated receptor gamma regulates implantation in mice. J Biol Chem 2004;279:11570-11581.
43. Lockwood CJ, Krikun G, Papp C et al. Biological mechanisms underlying the clinical effects of RU486: Modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. J Clin. Endo Metab 1995;80: 1100-1105.
44. Lockwood CJ, Krikun G, Hausknecht VA et al. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualisation and menstruation related progestin withdrawal. Endocrinology 1998; 139:4607-4613.
45. Maguer-Satta V, Bartholin L, Jeanpierre S et al. Expression of FLRG, a novel Activin-A ligand, is regulated, by TGF-beta and during hematopoiesis. Exp Hematob 2001;29:301-308.
46. Marbaix E, Vekemans M, Galant C et al. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinases-3) at the start of bleeding episodes in levonorgestrel-implant users. Hum Reprod 2000;15(Suppl 3),120-134.
47. Marions L, Danielsson KG. Expression of cyclo-oxygenase in human endometrium during the implantation period, Mol Hum Reprod 1999; 5: 961-965.
48. Miller C, Sassoon DA. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 1998;125:3201-3211.
49. Mohamed OA, Jonnaert M, Labelle-Dumais C et al. Uterine Wnt/ beta-catenin signalling is required for implantation. Proc Natl Acad Sci USA 2005;24:8579-8584.
50. Mousa SA, O'Connor LJ, Bergh JJ et al. The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol 2005;46:356-360.
51. Narvekar N, Critchley HO, Cheng L et al. Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor. Hum Reprod 2006;21:2312-2318.
52. Petersen A, Bentin-Ley U, Ravn V et al. The antiprogesterone Org 31710 inhibits human blastocyst-endometrial interactions in vitro. Fertil Steril 2005;83(Suppl 1):1255-1263.
53. Plaisier M, Kapiteijn K, Koolwijk P et al. Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: Role of MT3-MMP. J Clin Endo Metab 2004;89:5828-5836.
54. Ponnampalam AP, Weston GC, Trajstman AC et al. Molecular classification of human endometrial cycle stages by transcriptional profiling. Mol Hum Reprod 2004;10:879-893.
55. Poppe K, Velkeniers B. Female infertility and the thyroid. Best Pract Res Clin Endocrinol Metab 2004;18:153-165.
56. Riesewijk A, Martin J, van Os R et al. Gene expression profiling of human endometrial receptivity on days LH + 2 versus LH + 7 by microarray technology. Mol Hum Reprod 2003;9:253-264.
57. Rodgers WH, Matrisian LM, Giudice LC et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulations by steroid hormones. J Clin Invest 1994;94:946-953.
58. Rossi M, Sharkey AM, Vigano P et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction 2005;130:721-729.
59. Salamonsen LA, Lathbury LJ. Endometrial leukocytes and menstruation. Hum Reprod Update 2000;6:16-27.
60. Sang QX. Complex role of matrix metalloproteinases in angiogenesis. Cell Res 1998;8:171-177.
61. Sato Y, Higuchi T, Yoshioka S et al. Trophoblasts acquire a chemokine receptor, CCR1, as they differentiate towards invasive phenotype. Development 2003;130:5519-5532.
62. Sellitti DF, Akamizu T, Doi SQ et al. Renal expression of two 'thyroid-specific' genes: Thyrotropin receptor and thyroglobulin. Exp Nephrol 2000;8:235-243.
63. Talbi S, Hamilton AE, Vo KC et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006;147:1097-1121.
64. Wang H, Critchley HO, Kelly RW et al. Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 1998;4:407-412.
65. Zhang J, Hampton AL, Nie G et al. Progesterone inhibits activation of latent matrix metalloproteinase (MAP) -2 by membrane-type 1 MMP: enzymes co-ordinately expressed in human endometrium. Biol Reprod 2000;62: 85-94.